Fisher Scientific to Distribute Response Bio's Ramp Cardiac Product in Canada

According to Response Biomedical, the Canadian point-of-care market is expected to reach $66.2 million this year and to grow at 7 percent over the next few years.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.